Abraxane

95
http://www.rxwiki.com/sites/default/files/styles/scald-drxmin-thumb/public/rxwiki/bethmthumbnail_22.jpg
http://vcap.dailyrx.com/7d0e78cc-9182-45e0-9061-a1f7d70539c2.srt

Abraxane Overview

Reviewed: August 21, 2012
Updated: 

Abraxane is a prescription medication used to treat cancer, including breast, and lung, pancreatic cancer. Abraxane belongs to a group of drugs called antimicrotubule agents or taxanes. It works by stopping the growth and spread of cancer cells.

This medication comes in an injectable form to be given directly into a vein (IV) by a healthcare provider.

Common side effects of Abraxane include low blood cell count, hair loss, and joint or muscle pain.

Manufacturer

Abraxane Drug Class

Abraxane is part of the drug class:

Abraxane FDA Warning

Talk to your doctor or your pharmacist about the following black box warning for this medication:

WARNING: NEUTROPENIA

  • ABRAXANE therapy should not be administered to patients with metastatic breast cancer who have baseline neutrophil counts of less than 1,500 cells/mm3. In order to monitor the occurrence of bone marrow suppression, primarily neutropenia, which may be severe and result in infection, it is recommended that frequent peripheral blood cell counts be performed on all patients receiving ABRAXANE.
  • Note: An albumin form of paclitaxel may substantially affect a drug’s functional properties relative to those of drug in solution. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL FORMULATIONS.